IBDEI0TG ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13252,0)
 ;;=H40.43X3^^51^632^30
 ;;^UTILITY(U,$J,358.3,13252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13252,1,3,0)
 ;;=3^Inflam GLC,OU,Severe Stage
 ;;^UTILITY(U,$J,358.3,13252,1,4,0)
 ;;=4^H40.43X3
 ;;^UTILITY(U,$J,358.3,13252,2)
 ;;=^5005881
 ;;^UTILITY(U,$J,358.3,13253,0)
 ;;=H40.43X4^^51^632^31
 ;;^UTILITY(U,$J,358.3,13253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13253,1,3,0)
 ;;=3^Inflam GLC,OU,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,13253,1,4,0)
 ;;=4^H40.43X4
 ;;^UTILITY(U,$J,358.3,13253,2)
 ;;=^5005882
 ;;^UTILITY(U,$J,358.3,13254,0)
 ;;=H40.42X0^^51^632^22
 ;;^UTILITY(U,$J,358.3,13254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13254,1,3,0)
 ;;=3^Inflam GLC,OS,Stage Unspec
 ;;^UTILITY(U,$J,358.3,13254,1,4,0)
 ;;=4^H40.42X0
 ;;^UTILITY(U,$J,358.3,13254,2)
 ;;=^5005874
 ;;^UTILITY(U,$J,358.3,13255,0)
 ;;=H40.42X1^^51^632^23
 ;;^UTILITY(U,$J,358.3,13255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13255,1,3,0)
 ;;=3^Inflam GLC,OS,Mild Stage
 ;;^UTILITY(U,$J,358.3,13255,1,4,0)
 ;;=4^H40.42X1
 ;;^UTILITY(U,$J,358.3,13255,2)
 ;;=^5005875
 ;;^UTILITY(U,$J,358.3,13256,0)
 ;;=H40.42X2^^51^632^24
 ;;^UTILITY(U,$J,358.3,13256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13256,1,3,0)
 ;;=3^Inflam GLC,OS,Moderate Stage
 ;;^UTILITY(U,$J,358.3,13256,1,4,0)
 ;;=4^H40.42X2
 ;;^UTILITY(U,$J,358.3,13256,2)
 ;;=^5005876
 ;;^UTILITY(U,$J,358.3,13257,0)
 ;;=H40.42X3^^51^632^25
 ;;^UTILITY(U,$J,358.3,13257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13257,1,3,0)
 ;;=3^Inflam GLC,OS,Severe Stage
 ;;^UTILITY(U,$J,358.3,13257,1,4,0)
 ;;=4^H40.42X3
 ;;^UTILITY(U,$J,358.3,13257,2)
 ;;=^5133506
 ;;^UTILITY(U,$J,358.3,13258,0)
 ;;=H40.42X4^^51^632^26
 ;;^UTILITY(U,$J,358.3,13258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13258,1,3,0)
 ;;=3^Inflam GLC,OS,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,13258,1,4,0)
 ;;=4^H40.42X4
 ;;^UTILITY(U,$J,358.3,13258,2)
 ;;=^5005877
 ;;^UTILITY(U,$J,358.3,13259,0)
 ;;=H40.41X0^^51^632^17
 ;;^UTILITY(U,$J,358.3,13259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13259,1,3,0)
 ;;=3^Inflam GLC,OD,Stage Unspec
 ;;^UTILITY(U,$J,358.3,13259,1,4,0)
 ;;=4^H40.41X0
 ;;^UTILITY(U,$J,358.3,13259,2)
 ;;=^5005870
 ;;^UTILITY(U,$J,358.3,13260,0)
 ;;=H40.41X1^^51^632^18
 ;;^UTILITY(U,$J,358.3,13260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13260,1,3,0)
 ;;=3^Inflam GLC,OD,Mild Stage
 ;;^UTILITY(U,$J,358.3,13260,1,4,0)
 ;;=4^H40.41X1
 ;;^UTILITY(U,$J,358.3,13260,2)
 ;;=^5005871
 ;;^UTILITY(U,$J,358.3,13261,0)
 ;;=H40.41X2^^51^632^19
 ;;^UTILITY(U,$J,358.3,13261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13261,1,3,0)
 ;;=3^Inflam GLC,OD,Moderate Stage
 ;;^UTILITY(U,$J,358.3,13261,1,4,0)
 ;;=4^H40.41X2
 ;;^UTILITY(U,$J,358.3,13261,2)
 ;;=^5005872
 ;;^UTILITY(U,$J,358.3,13262,0)
 ;;=H40.41X3^^51^632^20
 ;;^UTILITY(U,$J,358.3,13262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13262,1,3,0)
 ;;=3^Inflam GLC,OD,Severe Stage
 ;;^UTILITY(U,$J,358.3,13262,1,4,0)
 ;;=4^H40.41X3
 ;;^UTILITY(U,$J,358.3,13262,2)
 ;;=^5133505
 ;;^UTILITY(U,$J,358.3,13263,0)
 ;;=H40.41X4^^51^632^21
 ;;^UTILITY(U,$J,358.3,13263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13263,1,3,0)
 ;;=3^Inflam GLC,OD,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,13263,1,4,0)
 ;;=4^H40.41X4
 ;;^UTILITY(U,$J,358.3,13263,2)
 ;;=^5005873
 ;;^UTILITY(U,$J,358.3,13264,0)
 ;;=H40.89^^51^632^68
 ;;^UTILITY(U,$J,358.3,13264,1,0)
 ;;=^358.31IA^4^2
